Vertex Appoints Michel Lagarde to its Board of Directors
Retrieved on:
Giovedì, Ottobre 5, 2023
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Michel Lagarde has been appointed to its Board of Directors as an independent director.
Key Points:
- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Michel Lagarde has been appointed to its Board of Directors as an independent director.
- Mr. Lagarde is a senior health care and business leader with global expertise, currently serving as Chief Operating Officer and Executive Vice President of Thermo Fisher Scientific Inc.
- “We are delighted to have Michel join the Vertex Board.
- “Vertex is at a very exciting time in its history as it builds on its success in cystic fibrosis using its serial innovation strategy,” said Michel Lagarde.